RAFFA WEALTH MANAGEMENT, LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $61.6K | Buy |
1,069
+34
| +3% | +$1.95K | 0.01% | 158 |
|
|
2026
Q1 | $62.8K | Buy |
1,035
+11
| +1% | +$641 | 0.01% | 148 |
|
|
2025
Q4 | $55.2K | Hold |
1,024
| – | – | 0.01% | 156 |
|
|
2025
Q3 | $46.2K | Sell |
1,024
-704
| -41% | -$32.9K | 0.01% | 166 |
|
|
2025
Q2 | $80K | Buy |
1,728
+717
| +71% | +$35.2K | 0.02% | 141 |
|
|
2025
Q1 | $61.7K | Sell |
1,011
-90
| -8% | -$5.25K | 0.01% | 136 |
|
|
2024
Q4 | $62.3K | Buy |
1,101
+40
| +4% | +$2.23K | 0.01% | 136 |
|
|
2024
Q3 | $54.9K | Hold |
1,061
| – | – | 0.01% | 140 |
|
|
2024
Q2 | $44.1K | Hold |
1,061
| – | – | 0.01% | 206 |
|
|
2024
Q1 | $57.5K | Sell |
1,061
-32
| -3% | -$1.63K | 0.02% | 183 |
|
|
2023
Q4 | $56.1K | Hold |
1,093
| – | – | 0.02% | 128 |
|
|
2023
Q3 | $63.4K | Hold |
1,093
| – | – | 0.02% | 111 |
|
|
2023
Q2 | $69.9K | Sell |
1,093
-200
| -15% | -$13.4K | 0.02% | 106 |
|
|
2023
Q1 | $89.6K | Hold |
1,293
| – | – | 0.03% | 106 |
|
|
2022
Q4 | $93K | Sell |
1,293
-171
| -12% | -$12.9K | 0.04% | 93 |
|
|
2022
Q3 | $104K | Buy |
1,464
+11
| +0.8% | +$798 | 0.05% | 80 |
|
|
2022
Q2 | $112K | Hold |
1,453
| – | – | 0.05% | 84 |
|
|
2022
Q1 | $106K | Hold |
1,453
| – | – | 0.04% | 86 |
|
|
2021
Q4 | $90.6K | Sell |
1,453
-15
| -1% | -$880 | 0.03% | 103 |
|
|
2021
Q3 | $86.9K | Buy |
1,468
+51
| +4% | +$3.36K | 0.03% | 84 |
|
|
2021
Q2 | $94.7K | Sell |
1,417
-1,107
| -44% | -$72.2K | 0.03% | 82 |
|
|
2021
Q1 | $159K | Buy |
2,524
+41
| +2% | +$2.55K | 0.06% | 76 |
|
|
2020
Q4 | $154K | Buy |
2,483
+35
| +1% | +$2.15K | 0.05% | 75 |
|
|
2020
Q3 | $148K | Sell |
2,448
-168
| -6% | -$10.1K | 0.06% | 70 |
|
|
2020
Q2 | $154K | Buy |
2,616
+18
| +0.7% | +$1.08K | 0.06% | 68 |
|
|
2020
Q1 | $145K | Sell |
2,598
-282
| -10% | -$17.2K | 0.05% | 65 |
|
|
2019
Q4 | $185K | Buy |
2,880
+1,287
| +81% | +$73.7K | 0.06% | 79 |
|
|
2019
Q3 | $80.8K | Buy |
+1,593
| New | +$74.9K | 0.03% | 100 |
|
|
2019
Q2 | – | Sell |
-840
| Closed | -$40.1K | – | 824 |
|
|
2019
Q1 | $40.1K | Hold |
840
| – | – | 0.02% | 125 |
|
|
2018
Q4 | $43.7K | Hold |
840
| – | – | 0.02% | 136 |
|
|
2018
Q3 | $52.1K | Hold |
840
| – | – | 0.02% | 136 |
|
|
2018
Q2 | $46.5K | Hold |
840
| – | – | 0.02% | 133 |
|
|
2018
Q1 | $53.1K | Buy |
840
+123
| +17% | +$7.91K | 0.02% | 118 |
|
|
2017
Q4 | $43.9K | Hold |
717
| – | – | 0.02% | 133 |
|
|
2017
Q3 | $45.7K | Hold |
717
| – | – | 0.02% | 136 |
|
|
2017
Q2 | $40K | Hold |
717
| – | – | 0.02% | 135 |
|
|
2017
Q1 | $39K | Sell |
717
-36
| -5% | -$1.98K | 0.02% | 115 |
|
|
2016
Q4 | $44K | Buy |
753
+100
| +15% | +$5.47K | 0.02% | 102 |
|
|
2016
Q3 | $35.2K | Hold |
653
| – | – | 0.02% | 106 |
|
|
2016
Q2 | $48K | Hold |
653
| – | – | 0.03% | 85 |
|
|
2016
Q1 | $41.7K | Sell |
653
-63
| -9% | -$3.97K | 0.02% | 106 |
|
|
2015
Q4 | $49.3K | Hold |
716
| – | – | 0.03% | 87 |
|
|
2015
Q3 | $42.4K | Hold |
716
| – | – | 0.03% | 98 |
|
|
2015
Q2 | $47.6K | Hold |
716
| – | – | 0.03% | 93 |
|
|
2015
Q1 | $46.2K | Buy |
716
+63
| +10% | +$3.94K | 0.03% | 84 |
|
|
2014
Q4 | $38.5K | Sell |
653
-500
| -43% | -$28.2K | 0.02% | 91 |
|
|
2014
Q3 | $59K | Buy |
1,153
+136
| +13% | +$6.79K | 0.04% | 70 |
|
|
2014
Q2 | $49.3K | Hold |
1,017
| – | – | 0.04% | 80 |
|
|
2014
Q1 | $52.8K | Buy |
1,017
+364
| +56% | +$19.4K | 0.04% | 74 |
|
|
2013
Q4 | $38.5K | Buy |
+653
| New | +$33.3K | 0.02% | 91 |
|
Other funds holding BMY
AIM
FWIA
DLA
RAFFA WEALTH MANAGEMENT, LLC's BMY Position: Q2 2026 in Review
RAFFA WEALTH MANAGEMENT, LLC increased its Bristol-Myers Squibb (BMY) stake by 3.3% in Q2 2026, buying an estimated $1.95K and bringing the position to 1,069 shares worth $61.6K. The position accounts for 0.01% of the portfolio, ranked #158.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in BMY in Q4 2013 and has held it in 50 quarters since. The position peaked at $185K in Q4 2019. 889 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC held 1,069 shares of Bristol-Myers Squibb worth $61.6K as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC bought 34 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.95K.
- Bristol-Myers Squibb made up 0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #158 holding.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 50 quarters since.
- RAFFA WEALTH MANAGEMENT, LLC's Bristol-Myers Squibb position peaked at $185K in Q4 2019.
- 889 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.